Annual ROE
-136.32%
-84.92%-165.21%
December 31, 2023
Summary
- As of February 22, 2025, PTIX annual return on equity is -136.32%, with the most recent change of -84.92% (-165.21%) on December 31, 2023.
- During the last 3 years, PTIX annual ROE has fallen by -358.00% (-161.49%).
- PTIX annual ROE is now -102.65% below its all-time high of 5138.10%, reached on June 30, 2014.
Performance
PTIX ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly ROE
-308.96%
-70.59%-29.61%
September 30, 2024
Summary
- As of February 22, 2025, PTIX quarterly return on equity is -308.96%, with the most recent change of -70.59% (-29.61%) on September 30, 2024.
- Over the past year, PTIX quarterly ROE has dropped by -70.59% (-29.61%).
- PTIX quarterly ROE is now -106.01% below its all-time high of 5142.86%, reached on June 30, 2014.
Performance
PTIX Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
PTIX ROE Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -165.2% | -29.6% |
| 3 y3 years | -161.5% | -29.6% |
| 5 y5 years | -111.2% | -29.6% |
PTIX ROE Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -199.7% | at low | -668.6% | at low |
| 5 y | 5-year | -149.4% | at low | -176.7% | at low |
| alltime | all time | -102.7% | +57.9% | -106.0% | +90.6% |
Protagenic Therapeutics ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -308.96%(+29.6%) |
| Jun 2024 | - | -238.37%(+52.4%) |
| Mar 2024 | - | -156.36%(+53.6%) |
| Dec 2023 | -136.32%(+165.2%) | -101.80%(+48.4%) |
| Sep 2023 | - | -68.58%(+29.7%) |
| Jun 2023 | - | -52.89%(+31.6%) |
| Mar 2023 | - | -40.20%(-11.6%) |
| Dec 2022 | -51.40%(+13.0%) | -45.47%(+1.4%) |
| Sep 2022 | - | -44.83%(+10.1%) |
| Jun 2022 | - | -40.73%(-13.3%) |
| Mar 2022 | - | -46.99%(-24.3%) |
| Dec 2021 | -45.49%(-120.5%) | -62.11%(-32.6%) |
| Sep 2021 | - | -92.18%(-64.6%) |
| Jun 2021 | - | -260.29%(-195.3%) |
| Mar 2021 | - | 273.01%(-9.3%) |
| Dec 2020 | 221.68%(-19.7%) | 301.03%(-21.5%) |
| Sep 2020 | - | 383.25%(+15.1%) |
| Jun 2020 | - | 332.90%(-1.0%) |
| Mar 2020 | - | 336.20%(-16.5%) |
| Dec 2019 | 275.99%(-77.2%) | 402.64%(-26.0%) |
| Sep 2019 | - | 544.33%(-60.4%) |
| Jun 2019 | - | 1376.29%(-141.7%) |
| Mar 2019 | - | -3298.26%(+427.9%) |
| Dec 2018 | 1212.66%(-754.4%) | -624.79%(+94.5%) |
| Sep 2018 | - | -321.24%(+46.9%) |
| Jun 2018 | - | -218.69%(+42.7%) |
| Mar 2018 | - | -153.21%(+17.9%) |
| Dec 2017 | -185.32%(+101.7%) | -129.95%(+25.9%) |
| Sep 2017 | - | -103.23%(+15.2%) |
| Jun 2017 | - | -89.58%(+10.0%) |
| Mar 2017 | - | -81.42%(+3.9%) |
| Dec 2016 | -91.87%(-195.9%) | -78.35%(-12.8%) |
| Sep 2016 | - | -89.90%(-30.7%) |
| Jun 2016 | - | -129.74%(-68.6%) |
| Mar 2016 | - | -412.85%(-555.7%) |
| Dec 2015 | - | 90.59%(-18.7%) |
| Sep 2015 | - | 111.49%(-25.0%) |
| Jun 2015 | 95.77%(-98.1%) | 148.63%(-35.0%) |
| Mar 2015 | - | 228.57%(-55.0%) |
| Dec 2014 | - | 507.86%(-51.0%) |
| Sep 2014 | - | 1036.36%(-79.8%) |
| Jun 2014 | 5138.10%(>+9900.0%) | 5142.86%(-1066.7%) |
| Jun 2013 | 5.96%(-105.1%) | - |
| Sep 2011 | - | -532.01%(+121.7%) |
| Jun 2011 | - | -239.98%(+65.1%) |
| Mar 2011 | - | -145.36%(+30.5%) |
| Dec 2010 | -117.71% | -111.40%(-18.4%) |
| Sep 2010 | - | -136.47%(+32.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2010 | - | -102.77%(+30.5%) |
| Mar 2010 | - | -78.78%(+24.9%) |
| Dec 2009 | -73.68%(-77.2%) | -63.06%(-61.5%) |
| Sep 2009 | - | -163.70%(+33.8%) |
| Jun 2009 | - | -122.35%(+26.5%) |
| Mar 2009 | - | -96.72%(-5.2%) |
| Dec 2008 | -323.76%(+605.7%) | -102.01%(>+9900.0%) |
| Sep 2008 | - | -0.14%(-94.9%) |
| Jun 2008 | - | -2.72%(-68.0%) |
| Mar 2008 | - | -8.50%(-70.2%) |
| Dec 2007 | -45.88%(-135.6%) | -28.57%(-2.2%) |
| Sep 2007 | - | -29.20%(-9.8%) |
| Jun 2007 | - | -32.39%(-39.6%) |
| Mar 2007 | - | -53.62%(-104.2%) |
| Dec 2006 | 128.83%(+184.1%) | - |
| Oct 2006 | - | 1269.57%(-1419.0%) |
| Jul 2006 | - | -96.25%(+376.0%) |
| Jul 2006 | 45.35%(-734.3%) | - |
| Apr 2006 | - | -20.22%(+60.9%) |
| Jan 2006 | - | -12.57%(-11.0%) |
| Oct 2005 | - | -14.13%(-1.2%) |
| Jul 2005 | -7.15%(-75.0%) | - |
| Jul 2004 | -28.62%(+419.4%) | - |
| Apr 2003 | - | -14.30%(+12.0%) |
| Jan 2003 | - | -12.77%(+24.2%) |
| Oct 2002 | - | -10.28%(+89.3%) |
| Jul 2002 | -5.51%(-615.0%) | -5.43%(+24.3%) |
| Apr 2002 | - | -4.37%(+49.1%) |
| Jan 2002 | - | -2.93%(+985.2%) |
| Oct 2001 | - | -0.27%(-125.7%) |
| Jul 2001 | 1.07%(-87.4%) | 1.05%(-80.7%) |
| Apr 2001 | - | 5.45%(-21.5%) |
| Jan 2001 | - | 6.94%(-9.2%) |
| Oct 2000 | - | 7.64%(-14.9%) |
| Jul 2000 | 8.50%(-271.7%) | 8.98%(+3107.1%) |
| Apr 2000 | - | 0.28%(-110.3%) |
| Jan 2000 | - | -2.73%(-34.1%) |
| Oct 1999 | - | -4.14%(-25.1%) |
| Jul 1999 | -4.95%(-204.0%) | -5.53%(-626.7%) |
| Apr 1999 | - | 1.05%(-77.1%) |
| Jan 1999 | - | 4.59%(-1.3%) |
| Oct 1998 | - | 4.65%(-1.5%) |
| Jul 1998 | 4.76%(-170.3%) | 4.72%(+60.0%) |
| Apr 1998 | - | 2.95%(+298.6%) |
| Jan 1998 | - | 0.74%(-119.9%) |
| Oct 1997 | - | -3.71%(-44.5%) |
| Jul 1997 | -6.77% | -6.68%(+29.2%) |
| Apr 1997 | - | -5.17%(+0.4%) |
| Jan 1997 | - | -5.15% |
FAQ
- What is Protagenic Therapeutics annual return on equity?
- What is the all time high annual ROE for Protagenic Therapeutics?
- What is Protagenic Therapeutics annual ROE year-on-year change?
- What is Protagenic Therapeutics quarterly return on equity?
- What is the all time high quarterly ROE for Protagenic Therapeutics?
- What is Protagenic Therapeutics quarterly ROE year-on-year change?
What is Protagenic Therapeutics annual return on equity?
The current annual ROE of PTIX is -136.32%
What is the all time high annual ROE for Protagenic Therapeutics?
Protagenic Therapeutics all-time high annual return on equity is 5138.10%
What is Protagenic Therapeutics annual ROE year-on-year change?
Over the past year, PTIX annual return on equity has changed by -84.92% (-165.21%)
What is Protagenic Therapeutics quarterly return on equity?
The current quarterly ROE of PTIX is -308.96%
What is the all time high quarterly ROE for Protagenic Therapeutics?
Protagenic Therapeutics all-time high quarterly return on equity is 5142.86%
What is Protagenic Therapeutics quarterly ROE year-on-year change?
Over the past year, PTIX quarterly return on equity has changed by -70.59% (-29.61%)